Overview
US managed healthcare provider's Q1 premium revenue fell 4% yr/yr due to lower Medicaid membership
Adjusted EPS for Q1 declined 61% yr/yr, impacted by impairment and contract expiration
Company reaffirmed full yr 2026 premium revenue and adjusted earnings guidance
Outlook
Molina Healthcare reaffirms 2026 premium revenue guidance of about $42 bln, down 2% from 2025
Company expects 2026 adjusted EPS of at least $5.00 and GAAP EPS of at least $1.90
Molina Healthcare plans to update 2026 guidance after second quarter results
Result Drivers
MEDICAID & MARKETPLACE MEMBERSHIP - Premium revenue declined due to lower Medicaid membership from market contraction and contract expiration, and decreased Marketplace membership from product and pricing strategy
MEDICARE ADVANTAGE IMPAIRMENT - Net income was reduced by a $93 mln impairment related to planned exit of Medicare Advantage-Part D product for 2027
MEDICAL COST TREND - Medical cost trend was modestly favorable to expectations, supporting MCR performance
Company press release: ID:nBw3Y3Nlta
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Premium Revenue
$10.17 bln
Q1 EPS
$0.27
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 15 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy."
Wall Street's median 12-month price target for Molina Healthcare Inc is $144.00, about 4.6% below its April 21 closing price of $151.00
The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 13 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)